Investigations on the biotransformation of mebendazole using an isolated perfused rat gut system

References

• Aitio A., Vainio H., Hänninen O. Enhancement of drug oxidation and conjugation by carcinogens in different rat tissues. FEBS Letters 1972; 24: 237
   PubMedGoogle Scholar
• Allgayer H., Härlin M., Weinzierl M., Bircher J., Baumgartner G. Mebendazoltherapie der Echinokokkose. Deutsche medizinische Wochenschrift 1984; 109: 1521
   PubMedGoogle Scholar
• Barr W. H., Riegelmann S. Intestinal drug absorption and metabolism. I: Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. Journal of Pharmaceutical Sciences 1970; 59: 154–163
   PubMed Web of Science ®Google Scholar
• Bock K. W., Winne D. Glucuronidation of 1-naphthol in the rat intestinal loop. Biochemical Pharmacology 1975; 24: 859–862
   PubMed Web of Science ®Google Scholar
• Bock K. W., Burchell B., Dutton G. J., Hänninen O., Mulder G. J., Owens I. S., Siest G., Tephly T. R. UDP-Glucuronosyltransferase activities, Guidelines for consistent interim terminology and assay conditions. Biochemical Pharmacology 1983; 12(6)953–955
   Google Scholar
• Braithwaite P. A., Roberts M. S., Allan R. J., Watson T. R. Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. European Journal of Clinical Pharmacology 1982; 22: 161–169
   PubMed Web of Science ®Google Scholar
• Brugmans J. P., Thienpont D. C., Van Wijngaarden I., Vanparijs O. F., Schuermans V. L., Lauwers H. L. Mebendazole in enterobiasis: Radiochemical and pilot clinical study in 1,278 subjects. Journal of the American Medical Association 1971; 217(3)313–316
   Google Scholar
• Dawson M., Allan R. J., Watson T. R. The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole. British Journal of Clinical Pharmacology 1982; 14: 453–455
   PubMed Web of Science ®Google Scholar
• Dawson M., Braithwaite P. A., Roberts M. S., Watson T. R. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. British Journal of Clinical Pharmacology 1985; 19: 79–86
   PubMed Web of Science ®Google Scholar
• Dawson M., Watson T. R. 4-Amino-3-(3′-methoxycarbonyl-2′-thio-ureido) benzophenone, a prodrug of mebendazole. European Journal of Drug Metabolism and Pharmacokinetics 1983; 8(4)329–334
   PubMedGoogle Scholar
• Dubey R. K., Singh J. Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine. I. Monooxygenases. Biochemical Pharmacology 1988a; 37(2)169–176
   PubMedGoogle Scholar
• Dubey R. K., Singh J. Localization and characterization of drug-metabolizing enzymes along the villus-crypt surface of the rat small intestine. II. Conjugases. Biochemical Pharmacology 1988b; 37(2)177–184
   PubMedGoogle Scholar
• Fisher R. B., Gardner M. L. G. A kinetic approach to the study of absorption of solutes by isolated perfused small intestine. Journal of Physiology 1974; 241: 211–234
   PubMedGoogle Scholar
• Fisher R. B., Parsons D. S. A preparation of surviving rat small intestine for the study of absorption. Journal of Physiology 1949; 110: 36–46
   PubMedGoogle Scholar
• Fishman W. H. β-Glucuronidase. Methoden der enzymatischen Analyse, H. U. Bergmeyer. Verlag Chemie, Weinheim/Bergstrasse 1974; Vol. I: 964–979
   Google Scholar
• Forth W., Rummel W. Wirkung von Herzglycosiden auf Calcium-, Natrium-, Wasser- und Glucosetransport am isolierten Dünndarm. Helvetica Physiologica Acta 1967; 25: 8–23
   PubMedGoogle Scholar
• George C. F., Gruchy B. S. Elimination of drugs by active intestinal transport. Journal of Pharmaceutical Pharmacology 1979; 31: 643–644
   PubMedGoogle Scholar
• Hietanen E., Laitinen M., Koivusaarl U. Effect of administration route of 3-methylcholanthrene on the inducibility of intestinal drug metabolizing enzymes. Enzyme 1980; 25: 153–157
   PubMedGoogle Scholar
• Hoensch H. P., Hartmann F. The intestinal enzymatic biotransformation system: potential role in protection from colon cancer. Hepato-Gastroenterologie 1981; 28: 221–228
   PubMedGoogle Scholar
• Iwamoto K., Klaassen K. C. First-pass effect of morphine in rats. Journal of Pharmacology and Experimental Therapeutics 1977; 200: 236–244
   PubMed Web of Science ®Google Scholar
• Josting D., Winne D., Bock K. W. Glucuronidation of paracetamol, morphine und 1-naphthol in the rat intestinal loop. Biochemical Pharmacology 1976; 25: 613–616
   PubMed Web of Science ®Google Scholar
• Kern P., Dietrich M., Volkmer K. J. Chemotherapy of echinococcosis with mebendazole Clinical observations of 7 patients. Tropenmedizinische Parasitologie 1979; 30: 65–72
   PubMedGoogle Scholar
• Klippert P. J. M., Littel R. J. J., Noordhoek J. In vivo O-deethylation of phenacetin in 3-methylcholanthrene pretreated rats. Gut wall and liver first- metabolism. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 153–157
   PubMed Web of Science ®Google Scholar
• Kolossa N., Schutzenberger W. G., Wiener H., Turnheim K. Active secretion of hypoxanthine and xanthine by guinea pig jejunum in vitro. American Journal of Physiology 1980; 238: G141–149
   Google Scholar
• Kreidel I., Kroker R., Ungemach F. R. Secondary bioavailability of mebendazole: Studies in the isolated perfused liver and isolated hepatocytes. Proceedings of the EURORESIDUE Conference, N. Haagsma, A. Ruiter, P. B. Czedik-Eysenberg. Noordwijkerhout, The Netherlands 1990; 248–253
   Google Scholar
• Kreidel I., Ungemach F. R., Kroker R., Homann J. Metabolismus von Mebendazol in Rattenhepatozyten unter dem Einfluss von Cimetidin. Gastroenterologie 1987; 25: 11–12
   Google Scholar
• Luder P. J., Siffert B., Witassek F., Meister F., Bircher J. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. European Journal of Clinical Pharmacology 1986; 31: 443–448
   PubMed Web of Science ®Google Scholar
• Meuldermans W. E. G., Hurkmans R. M. A., Lauwers W. F. J., Heykants J. J. P. The in vitro metabolism of mebendazole by pig, rat and dog liver fractions. European Journal of Drug Metabolism and Pharmacokinetics 1976; I: 35–40
   Google Scholar
• Münst G. J., Karlaganis G., Bircher J. Plasma concentrations of mebendazole during treatment of echinococcosis. Preliminary results. European Journal of Clinical Pharmacology 1980; 17: 375–378
   PubMed Web of Science ®Google Scholar
• Pappalardo G., Reggio D., Frattaroli F. M., Teggi A., Correnti F. S., Castrini G. Combined medical and surgical therapy: a new approach to abdominal hydatidosis. Italian Journal of Surgical Sciences 1987; 17(4)335–339
   PubMedGoogle Scholar
• Pekas J. C. Naphthol metabolism: Glucuronide conjugation and transport by the rat intestine in vitro. Toxicology and Applied Pharmacology 1974; 29: 404–419
   PubMed Web of Science ®Google Scholar
• Richter E., Strugala G. J. An ail-glass perfusator for investigation of the intestinal transport and metabolism of foreign compounds in vitro. Journal of Pharmacological Methods 1985; 14: 297–304
   PubMedGoogle Scholar
• Rod T. O., Midtvedt T. Origin of intestinal β-glucuronidase in germfree, monocontaminated, and conventional rats. Acta Pathologica et Microbiologica Scandinavica/B Microbiology 1977; 85: 271–276
   Google Scholar
• Scharf R., Ullrich V. In vitro induction by phenobarbital of drug monooxygenase activity in mouse small intestine. Biochemical Pharmacology 1974; 23: 2127–2137
   PubMed Web of Science ®Google Scholar
• Siest G., Boutin J. A., Magdalou J., Batt A. M., Antoine B., Fourmel S., Thomassin J. UDP-glucuronyltransferases et glucuronoconjugation. Therapie 1985; 40: 139–153
   PubMedGoogle Scholar
• Sund R. B., Lauterbach F. Intestinal secretion of sulphanilic acid by the isolated mucosa of guinea pig jejunum. Acta Pharmaceutica Toxicologica 1980; 43: 331–338
   Google Scholar
• Turnheim K., Lauterbach F. Interaction between intestinal absorption and secretion of monoquarternary ammonium compounds in guinea-pig—A concept for the absorption kinetics of organic cations. Journal of Pharmacology and Experimental Therapeutics 1980; 212: 418–424
   PubMed Web of Science ®Google Scholar
• Van Den Bossche H. Biochemical effects of the anthelmintic drug mebendazole. Comparative Biochemistry of Parasites, H. Van den Bossche. Academic Press, New York 1972; 139–157
   Google Scholar
• Van Den Bossche H. Mebendazole. Chemotherapy of Gastrointestinal Helminths, H. Van den Bossche, M. H. Mirck, F. Rochette, W. S. Kammerer. Springer Verlag, Berlin 1985; 148
   Google Scholar
• Werner W., Rey H. G., Wielinger H. Über die Eigenschaften eines neuen Chromogens für die Blutzuckerbestimmung nach der GOD/POD-Methode. Zentralblatt für Analytische Chemie 1970; 252: 224–228
   Google Scholar
• Witassek F., Bircher J. Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level. European Journal of Clinical Pharmacology 1983; 25: 85–90
   PubMed Web of Science ®Google Scholar
• Witassek F., Burckhardt B., Eckert J., Bircher J. Chemotherapy of alveolar echinococcosis. Comparison of plasma mebendazole concentrations in animals and in man. European Journal of Clinical Pharmacology 1981; 20: 427–433
   PubMed Web of Science ®Google Scholar
• Wollenberg P., Ullrich V., Rummel W. Conjugation of 1-naphthol and transport of 1-naphthol-conjugates in the vascularly perfused small intestine. Biochemical Pharmacology 1983; 32(13)2103–2107
   PubMedGoogle Scholar
• Yasuhara M., Kurosaki Y., Kimura T., Sezaki H. Drug elimination function of rat small intestine: metabolism and intraluminal excretion. Biochemical Pharmacology 1984; 33(20)3131–3136
   PubMedGoogle Scholar